Mater Clinical Trials

Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health.  Clinical trials are an essential component of healthcare.  They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs. 

Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.

Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.

A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
Trial Status:
Recruiting
|
Contact:
IBD Clinical Trials Unit
Duloxetine versus pregabalin to treat opioid-resistant nerve pain in cancer patients
Trial Status:
Recruiting
|
Contact:
Mater Palliative and Supportive Care Research
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men with Locally Advanced or Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation.
Trial Status:
Not yet recruiting
|
Contact:
Kathryn Middleton
Study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD Emphysema
Trial Status:
Recruiting
|
Contact:
RIO Clinical Trials Unit
A new treatment for Ulcerative Colitis (UC)
Trial Status:
Recruiting
|
Contact:
Sharyn Grossman
A study investigating the effectiveness & safety of Dupilumab in the treatment of eosinophilic gastritis with or without eosinophilic duodenitis.
Trial Status:
Recruiting
|
Contact:
IBD Clinical Trials
Testing the safety and effectiveness of Fenofibrate in reducing diabetic retinopathy in adults with Type 1 diabetes
Trial Status:
Recruiting
|
Contact:
Yvonne Gautam
A clinical trial of investigational drug tafasitamab plus lenalidomide in addition to standard therapy for treatment of newly diagnosed high and intermediate risk diffuse large B-cell lymphoma (DLBCL)
Trial Status:
Active, not recruiting
|
Contact:
Kim Green - Clinical Research Coordinator
FUZION: Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease
Trial Status:
Recruiting
|
Contact:
Sharyn Grossman
This study is investigating the safety of administering heated (42 degrees Celsius) versus normal temperature (37 degrees Celsius) chemotherapy during surgery for ovarian cancer patients.
Trial Status:
Recruiting
|
Contact:
Claire Jackson
Displaying results 11-20 (of 61)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7  >  >|